Medicare Enrolled
Dr. Stephen Martino, M.D.
Optician · Brick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martino
Dr. Stephen Martino is an optician specialist in Brick, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martino performed 2,495 Medicare services across 1,639 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martino received a total of $80,566 from 88 pharmaceutical and/or device companies across 1307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in NJ
$80,566 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,495
Medicare services
Top 27% in NJ for optician
1,639
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
740 | $98 | $170 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
529 | $27 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
206 | $130 | $350 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
170 | $143 | $350 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
149 | $193 | $325 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
130 | $327 | $422 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
96 | $16 | $242 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
84 | $188 | $450 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
81 | $108 | $325 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
68 | $86 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
40 | $67 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $71 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $146 | $375 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
23 | $115 | $300 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
21 | $38 | $1,800 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
20 | $99 | $1,800 |
| Placement of skin electrodes and measurement of stimulated sites in legs This procedure involves placing skin electrodes on the legs and measuring the sites where stimulation is applied. |
19 | $23 | $500 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $65 | $150 |
| Needle EMG of muscles on both sides of body A test that measures the electrical activity in muscles using a needle electrode. The procedure is performed on muscles located on both sides of the body. |
16 | $51 | $500 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
13 | $91 | $375 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
12 | $367 | $462 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$80,566
Total received (2018-2024)
Avg $11,509/year across 7 years
Top 3% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,307
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,884 (80.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,617 (18.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,065 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,222
2023
$8,960
2022
$21,570
2021
$20,291
2020
$17,634
2019
$2,355
2018
$1,534
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,532
PFIZER INC.
$524
Novartis Pharmaceuticals Corporation
$402
Celgene Corporation
$292
ARGENX US, INC.
$161
EMD Serono, Inc.
$157
UCB, Inc.
$144
Lundbeck LLC
$134
Lilly USA, LLC
$133
Alexion Pharmaceuticals, Inc.
$108
Teva Pharmaceuticals USA, Inc.
$97
SK Life Science, Inc.
$65
Ipsen Biopharmaceuticals, Inc
$49
Neurocrine Biosciences, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$46
Otsuka America Pharmaceutical, Inc.
$42
CSL Behring
$36
CATALYST PHARMACEUTICALS, INC.
$33
Grifols USA, LLC
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Neurelis, Inc.
$29
Aucta Pharmaceuticals, Inc.
$25
Amylyx Pharmaceuticals, Inc.
$20
Nevro Corp.
$19
Amneal Pharmaceuticals LLC
$17
REVANCE THERAPEUTICS, INC.
$17
Eisai Inc.
$15
Biogen, Inc.
$14
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$31,040
Allergan, Inc.
$19,332
AbbVie Inc.
$14,515
Novartis Pharmaceuticals Corporation
$1,793
Teva Pharmaceuticals USA, Inc.
$1,160
Biohaven Pharmaceutical Holding Company Ltd.
$1,065
PFIZER INC.
$950
UCB, Inc.
$949
Alexion Pharmaceuticals, Inc.
$871
Celgene Corporation
$744
EMD Serono, Inc.
$588
Lilly USA, LLC
$545
Biogen, Inc.
$511
NOVARTIS PHARMACEUTICALS CORPORATION
$477
Amgen Inc.
$394
ARGENX US, INC.
$347
SK Life Science, Inc.
$330
Lundbeck LLC
$273
Genentech USA, Inc.
$211
GENZYME CORPORATION
$192
Amneal Pharmaceuticals LLC
$188
Kyowa Kirin, Inc.
$183
E.R. Squibb & Sons, L.L.C.
$178
Ipsen Biopharmaceuticals, Inc
$167
EISAI INC.
$165
Eisai Inc.
$164
Neurelis, Inc.
$156
Biohaven Pharmaceuticals, Inc.
$153
Janssen Pharmaceuticals, Inc
$144
Supernus Pharmaceuticals, Inc.
$138
Sumitomo Pharma America, Inc.
$130
Allergan Inc.
$129
Merz North America, Inc.
$107
Novocure Inc.
$97
Silk Road Medical, Inc.
$95
Mallinckrodt Hospital Products Inc.
$89
Neurocrine Biosciences, Inc.
$87
Currax Pharmaceuticals LLC
$86
CSL Behring
$86
Grifols USA, LLC
$85
Avanir Pharmaceuticals, Inc.
$84
Boston Scientific Corporation
$80
Otsuka America Pharmaceutical, Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$74
SCILEX PHARMACEUTICALS INC.
$70
Amylyx Pharmaceuticals, Inc.
$67
Merz Pharmaceuticals, LLC
$63
NEUROPACE, INC.
$59
Corium, LLC
$58
Avion Pharmaceuticals
$56
Medtronic USA, Inc.
$55
AbbVie, Inc.
$55
GE HealthCare
$53
Piramal Imaging Limited
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Nevro Corp.
$42
Impax Laboratories, Inc.
$42
Horizon Therapeutics plc
$41
Acorda Therapeutics, Inc
$41
Adamas Pharmaceuticals, Inc.
$38
CATALYST PHARMACEUTICALS, INC.
$33
ACADIA Pharmaceuticals Inc
$29
Scilex Pharmaceuticals Inc.
$28
AstraZeneca Pharmaceuticals LP
$28
US WorldMeds, LLC
$26
Aucta Pharmaceuticals, Inc.
$25
Bausch Health US, LLC
$25
Egalet US Inc
$24
MERZ NORTH AMERICA, INC.
$20
REVANCE THERAPEUTICS, INC.
$17
UPSHER-SMITH LABORATORIES LLC
$16
Banner Life Sciences, LLC
$16
Catalyst Pharmaceuticals, Inc.
$15
AQUESTIVE THERAPEUTICS, INC.
$15
Jazz Pharmaceuticals Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Collegium Pharmaceutical, Inc.
$14
Vertical Pharmaceuticals, LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
MDD US Operations, LLC
$14
Mallinckrodt Enterprises LLC
$14
Assertio Therapeutics, Inc.
$14
PORTOLA PHARMACEUTICALS, INC.
$13
Akcea Therapeutics, Inc.
$13
Xeris Pharmaceuticals, Inc.
$12
Almatica Pharma LLC
$12
Saol Therapeutics Inc.
$12
Upsher-Smith Laboratories LLC
$11
Top 3 companies account for 80.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cenobamate · DAXI · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · Enspryng · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · General - DBS · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAPRELAN · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONZETRA XSAIL · Optune · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · RELEXXII · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Senza · Soliris · Strensiq · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN FLX · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZTLido · Zilbrysq · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in NJ.
Geographic Context
Opticians within 10 mi
328
Per 100K population
50.7
County median income
$86,411
Nearest hospital
OCEAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martino is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NJ), with speaking/promotional industry engagement in the top 3% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martino experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Martino performed 740 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martino receive payments from pharmaceutical companies?
Yes. Dr. Martino received a total of $80,566 from 88 companies across 1,307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martino's costs compare to other opticians in Brick?
Dr. Martino's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Brick
Browse opticians in Brick ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology